The Effect of IEQ on Cognition and Health (IEQ-HUM)

March 20, 2025 updated by: Maastricht University Medical Center

The Effect of the Indoor Environmental Quality (IEQ) on Cognition and Health

The goal of this study is to learn about the effect of heat and humidity on cognition and health. The main question[s] it aims to answer are:

type of study: interventional participant population: 20-40years, both gender, healthy Participants will be exposed for 4 different sessions of 8 hours at a time, to 32˚ C or 25˚ C in combination with relative humidity of 30 %RH or 70 %RH.

Study Overview

Detailed Description

Overall, the project aims to evaluate the effects of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognition, for longer exposure duration (8 hours). Deviations from the personal comfort zones are expected to affect both subjective feelings and physiological parameters. Therefore, the following parameters will be included: cognition, environmental perception, energy expenditure, body temperatures.

Main research question and primary objective:

What is the impact of being exposed for 8 hours to a high humidity (RH 70%) versus low humidity (RH 30%) on cognitive performance of individuals if the room temperature is 25ºC or 32ºC?

This leads to the following hypotheses:

  • Exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at the same temperature (32ºC) due to the humidity.
  • An exposure to an indoor high relative humidity (RH 70%) at a neutral temperature (25ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at a neutral temperature (25 ºC) due to previous literature for humidity influences at neutral temperatures.

Secondary research question and secondary objective:

What is the effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on physiological responses, environmental perception, decision making, and bias behaviour?

This leads to the following hypotheses:

  1. Does an 8 hour exposure to an elevated concentration of indoor humidity lead to an increase in energy expenditure and/or a greater difference in proximal and distal blood flow and skin temperature gradients compared to a lower indoor humidity for each of the temperature settings?
  2. What are the effects of high humidity on substrate oxidation, blood pressure, heart rate variability, proximal and distal skin temperature, risk behavior and decision-making responses of individuals?
  3. What are the effects of higher humidity on environmental perception (thermal, air quality, moisture/wetness) comfort, perception, and sensation?

    • An exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a high RH (70%) at a neutral temperature (25 ºC) due to the humidity and temperature.
    • An exposure to an indoor low relative humidity (RH 30%) at a warm temperature (32ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to the same low RH (30%) at a neutral temperature (25 ºC) due to the temperature.

Exploratory research question and objective:

What is the interaction effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognitive performance, physiological responses, environmental perception, decision making, and bias behaviour?

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Maastricht, Netherlands
        • Maastricht University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • BMI between 18.5-26 kg/m2
  • Age between 20-40 years
  • Proficient with the English language in both verbal and written form
  • Healthy; no illness or disease or prescribed medication within the last 3 months
  • Steady dietary and sleeping habits
  • Regularly physically active (i.e., regularly active but less than 3 times a week for less than 2 hours per session at moderate intensity)
  • Non-smoker or person who quit smoking more than five years ago
  • Reside in the Netherlands (or surrounding countries) for at least 6 months

Exclusion Criteria:

  • Subjects with cardiac problems and cardiovascular diseases, such as angina pectoris, cardiac infarction, and arrhythmias
  • Subjects with any medical condition requiring treatment and/or medication (except oral contraceptives) that might interfere with the investigated parameters E.g., Extreme chronotype, colour blindness, epilepsy
  • Subjects with a disorder or disease (Parkinson, Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer, diabetes, cardiovascular disorder, respiratory impairments (for example asthma), hypertension, obesity, or any other condition that can impair the lung function), or Raynaud's phenomenon
  • Subjects with abnormal diet and sleeping patters and/or abnormal body weight (weight gain or loss >3kg in the past month)
  • Subjects who recently participated in other interventional biomedical study within 1 month prior to screening visit
  • Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician will be informed, cannot participate in this study
  • Subjects with previous covid infection in the past 3 months or any subject with persistent long covid symptoms that may have caused ongoing loss of or altered sense of smell
  • Subjects who had severely altered sleep patterns in the past year
  • Subjects employed with night shift work within the past year
  • Subjects who consume more than two standard drinks of alcohol per day
  • Subjects who consume more than two standard drinks of coffee per day
  • Subjects who are pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Temperature and Humidity
32C or 25C and 30%RH or 70%RH
Temperature and Humidity of room changed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognition
Time Frame: 1 month
Using a tablet based cognitive test battery
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate (bpm)
Time Frame: 1 month
Heart Rate measured using Polar heart rate belt in (bpm) with RR and ECG data extracted
1 month
Blood pressure (mmHg)
Time Frame: 1 month
Blood pressure - both systolic and diastolic pressures measured hourly using an automated blood pressure monitor and cuff
1 month
Metabolic Rate (ml O2//min/kg)
Time Frame: 1 month
Metabolic rates measured through whole room calorimetry
1 month
Skin Temperature (C)
Time Frame: 1 month
Skin temperature measured using thermochron (ibuttons) at multiple sites
1 month
Body Core Temperature (C)
Time Frame: 1 month
Core Temperature measured via telemetric pill ingested in the morning
1 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Room Temperature (C)
Time Frame: 1 month
Environmental measures are measured continuously using temperature specific sensors in the room
1 month
Humidity (%)
Time Frame: 1 month
Environmental measures are measured continuously using humidity specific sensors in the room
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guy Plasqui, PHD, Maastricht University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 18, 2023

Primary Completion (Actual)

May 7, 2024

Study Completion (Actual)

May 7, 2024

Study Registration Dates

First Submitted

March 24, 2023

First Submitted That Met QC Criteria

July 25, 2023

First Posted (Actual)

August 2, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 20, 2025

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NL81104.068.22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

If requested raw data will be provided.

IPD Sharing Time Frame

Ongoing, depends on the request.

IPD Sharing Access Criteria

Official request made stating the purpose of use for the data. Only individuals that consent to their data to be used in further analysis will be shared.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Temperature and Humidity

Subscribe